We are live on
!
Find out more
AA
AlphaMark Advisors Portfolio holdings
AUM
$231M
1-Year Est. Return
19.98%
This Fund
S&P 500
This Quarter
Est. Return
+3.02%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$194M
AUM Growth
-$4.43M
(-2.2%)
Cap. Flow
+$38.3M
Cap. Flow
% of AUM
19.78%
Top 10 Holdings %
Top 10 Hldgs %
32.5%
Holding
489
New
146
Increased
58
Reduced
57
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$46.2M |
| 2 |
IBDH
iShares iBonds Dec 2018 Term Corporate ETF
IBDH
|
+$1.41M |
| 3 |
SAFM
Sanderson Farms Inc
SAFM
|
+$814K |
| 4 |
CUDA
Barracuda Networks, Inc.
CUDA
|
+$631K |
| 5 |
Ventas
VTR
|
+$454K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.79M |
| 2 |
Qorvo
QRVO
|
+$2.17M |
| 3 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$1.35M |
| 4 |
Wabash National
WNC
|
+$939K |
| 5 |
The Greenbrier Companies
GBX
|
+$895K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.38% |
| 2 | Industrials | 11.28% |
| 3 | Consumer Discretionary | 9.78% |
| 4 | Healthcare | 9.65% |
| 5 | Financials | 9.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lear
LEA
$6.54B
| $2.91M | 1.5% |
22,014
-856
| -4% | -$108K |
|
27
Tyson Foods
TSN
$20.4B
| $2.88M | 1.48% |
46,608
-7,095
| -13% | -$466K |
|
|
FFH
28
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
| $2.81M | 1.45% |
5,768
-268
| -4% | -$130K |
|
29
Cadence Design Systems
CDNS
$93.6B
| $2.73M | 1.41% |
108,224
-7,606
| -7% | -$196K |
|
30
KLA
KLAC
$239B
| $2.63M | 1.36% |
334,170
-7,720
| -2% | -$59K |
|
31
Celanese
CE
$4.9B
| $2.54M | 1.31% |
32,308
-2,001
| -6% | -$150K |
|
32
Estee Lauder
EL
$30.4B
| $2.47M | 1.28% |
32,326
+409
| +1% | +$33.2K |
|
33
US Bancorp
USB
$98.2B
| $2.46M | 1.27% |
47,837
+1,000
| +2% | +$47.6K |
|
34
Eastman Chemical
EMN
$8B
| $2.31M | 1.19% |
30,733
-790
| -3% | -$57.1K |
|
35
PVH
PVH
$4B
| $1.96M | 1.01% |
21,710
+837
| +4% | +$88.1K |
|
36
Lumen
LUMN
$6.57B
| $1.91M | 0.98% |
80,196
-1,859
| -2% | -$47.2K |
|
|
IBDH
37
DELISTED
iShares iBonds Dec 2018 Term Corporate ETF
IBDH
| $1.79M | 0.92% |
71,306
+56,181
| +371% | +$1.41M |
|
38
iShares TIPS Bond ETF
TIP
$14.5B
| $1.66M | 0.86% |
14,638
+180
| +1% | +$20.6K |
|
39
AMN Healthcare
AMN
$1.3B
| $1.33M | 0.69% |
34,610
+7,400
| +27% | +$253K |
|
40
Stride
LRN
$3.41B
| $1.29M | 0.66% |
74,934
| – | – |
|
|
GNCA
41
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.26M | 0.65% |
38,103
+9,750
| +34% | +$321K |
|
42
Employers Holdings
EIG
$922M
| $1.18M | 0.61% |
29,904
| – | – |
|
43
Welltower
WELL
$169B
| $1.11M | 0.57% |
16,538
+925
| +6% | +$61.3K |
|
|
RP
44
DELISTED
RealPage, Inc.
RP
| $1.11M | 0.57% |
36,900
| – | – |
|
45
Enanta Pharmaceuticals
ENTA
$366M
| $1.11M | 0.57% |
33,000
| – | – |
|
46
MaxLinear
MXL
$6.06B
| $1.09M | 0.56% |
50,000
| – | – |
|
47
Coherent
COHR
$51.4B
| $1.09M | 0.56% |
36,626
| – | – |
|
48
Cooper-Standard Automotive
CPS
$523M
| $1.08M | 0.56% |
10,500
| – | – |
|
49
Cirrus Logic
CRUS
$6.53B
| $1.05M | 0.54% |
18,604
| – | – |
|
50
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $1.04M | 0.54% |
4,665
+200
| +4% | +$43.7K |
|
Similar funds
AJ
MWS
LHR
HPFG
GWM
KC
SL
CSWM
AlphaMark Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, AlphaMark Advisors held 489 positions worth $194M, down 2.2% from $198M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
AlphaMark Advisors deployed $38.3M of net new capital in Q4 2016, opening 146 new positions and adding to 58 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 200 shares worth $488K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $2.79M trimmed.
- AlphaMark Advisors's largest Q4 2016 buy was Berkshire Hathaway Class A: 200 shares worth $488K.
- AlphaMark Advisors added most to iShares iBonds Dec 2018 Term Corporate ETF in Q4 2016, an estimated $1.41M increase.
- AlphaMark Advisors's biggest Q4 2016 reduction was Jazz Pharmaceuticals, cutting an estimated $2.79M.
- AlphaMark Advisors fully exited Wabash National in Q4 2016, selling an estimated $939K.
- AlphaMark Advisors's ten largest holdings make up 33% of its $194M portfolio in Q4 2016.
- AlphaMark Advisors opened 146 new positions and closed 22 in Q4 2016.
- AlphaMark Advisors's portfolio value fell 2.2% quarter-over-quarter to $194M.
Based on AlphaMark Advisors's 13F filing for Q4 2016, filed 26 Jan 2017.